BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, February 11, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2011
View Archived Issues
Anchor Therapeutics presents new chemokine CXCR4 receptor agonists
Read More
Clinical investigation of NPSP-558 for hypoparathyroidism updated
Read More
Novel glucocorticoid receptor modulators may have fewer side effects than steroids
Read More
Applied Genetic Technologies receives grant for X-linked retinoschisis gene therapy
Read More
Japanese MHLW adds fenofibrate tablets to NHI price list
Read More
GetGoal-F1 results add to phase III data on lixisenatide in type 2 diabetes
Read More
Pilot trial investigates new protocol for treatment of severe pemphigus
Read More
Phase I data on Ad26.ENVA.01 in HAdV-26-seronegative and -seropositive HIV-1-uninfected adults
Read More
Randomized trial assesses estetrol in women with ER-positive early-stage breast cancer
Read More
Korean university synthesizes new PPAR-beta/delta ligands
Read More
New Mnk inhibitors patented by Boehringer Ingelheim
Read More
Spanish research teams disclose new anticancer cyclic peptides
Read More
New recombinant PEGylated FVIII molecules prepared at Novo Nordisk
Read More
Theraclone Sciences begins phase I trial of TCN-032
Read More
BMS and Ambrx establish partnership for biologics
Read More
Biofrontera submits final documents to address BF-200 ALA NDA
Read More
Zymeworks secures financing for antibody technology and pipeline programs
Read More
Acetylon Pharmaceuticals initiates phase I/IIa ACY-1215 study
Read More
ACT clear to conduct phase I/II stem cell therapy trial in U.K.
Read More
EMA committee recommends extending approval of Levemir
Read More
Shire provides update on ProAmatine in U.S.
Read More
RXi acquires worldwide license for vaccine candidate targeting gynecological cancers
Read More
EMA confirms positive benefit-to-risk balance for Multaq
Read More
ImmunoGen submits IND for anticancer candidate
Read More
